EDITORIAL
Published on 07 Aug 2023
Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals
doi 10.3389/fphar.2023.1266168
- 1,074 views
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- Hepatic insulin resistance and related obesity: Highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals.
Hepatic insulin resistance and related obesity: Highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals.
6,904
Total downloads
24k
Total views and downloads
Articles
REVIEW
Published on 30 Jun 2023
Role of NLRP3 inflammasome and oxidative stress in hepatic insulin resistance and the ameliorative effect of phytochemical intervention
doi 10.3389/fphar.2023.1188829
- 3,197 views
- 9 citations
ORIGINAL RESEARCH
Published on 12 May 2023
Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design
doi 10.3389/fphar.2023.1190458
- 2,423 views
- 3 citations
CLINICAL TRIAL
Published on 14 Mar 2023
The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial
doi 10.3389/fphar.2023.1149967
- 1,826 views
- 3 citations
ORIGINAL RESEARCH
Published on 16 Dec 2022
Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
doi 10.3389/fphar.2022.1081553
- 2,114 views
- 11 citations
ORIGINAL RESEARCH
Published on 19 Jan 2022
Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice
doi 10.3389/fphar.2021.770652
- 6,167 views
- 4 citations
ORIGINAL RESEARCH
Published on 19 Feb 2021
Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
doi 10.3389/fphar.2020.591293
- 2,720 views
- 5 citations
